Ascentage Pharma Group International (AAPG) Other Working Capital Changes (2024 - 2025)
Historic Other Working Capital Changes for Ascentage Pharma Group International (AAPG) over the last 3 years, with Q2 2025 value amounting to $22.4 million.
- Ascentage Pharma Group International's Other Working Capital Changes changed N/A to $22.4 million in Q2 2025 from the same period last year, while for Jun 2025 it was $22.4 million, marking a year-over-year change of. This contributed to the annual value of $16.9 million for FY2024, which is 162137.87% up from last year.
- Latest data reveals that Ascentage Pharma Group International reported Other Working Capital Changes of $22.4 million as of Q2 2025.
- Ascentage Pharma Group International's Other Working Capital Changes' 5-year high stood at $22.4 million during Q2 2025, with a 5-year trough of $12.3 million in Q4 2023.
- In the last 3 years, Ascentage Pharma Group International's Other Working Capital Changes had a median value of $17.2 million in 2024 and averaged $17.3 million.
- The largest annual percentage gain for Ascentage Pharma Group International's Other Working Capital Changes in the last 5 years was 3989.04% (2024), contrasted with its biggest fall of 3989.04% (2024).
- Over the past 3 years, Ascentage Pharma Group International's Other Working Capital Changes (Quarter) stood at $12.3 million in 2023, then skyrocketed by 39.89% to $17.2 million in 2024, then surged by 30.47% to $22.4 million in 2025.
- Its Other Working Capital Changes stands at $22.4 million for Q2 2025, versus $17.2 million for Q4 2024 and $12.3 million for Q4 2023.